Global Hemostatic Powder Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hemostatic Powder market size is projected to grow from US$ 378 million in 2022 to US$ 471.7 million in 2029; it is expected to grow at a CAGR of 471.7 from 2023 to 2029.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 66%.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
LPI (LP Information)' newest research report, the “Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Hemostatic Powder sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostatic Powder sales for 2023 through 2029. With Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Powder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Hemostatic Powder market?
What factors are driving Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic Powder market opportunities vary by end market size?
How does Hemostatic Powder break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Hemostatic Powder market size is projected to grow from US$ 378 million in 2022 to US$ 471.7 million in 2029; it is expected to grow at a CAGR of 471.7 from 2023 to 2029.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 66%.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
LPI (LP Information)' newest research report, the “Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Hemostatic Powder sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostatic Powder sales for 2023 through 2029. With Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Powder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Absorbable Hemostatic Agent
- Not Absorbable Hemostatic Agent
- Hospital
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- BD
- Baxter
- B.Braun
- Cura Medical
- GELITA MEDICAL
- Curasan AG
- Meril Life Sciences
- Zhonghui Shengxi
- Beijing Datsing Bio-tech
- Guizhou Jin Jiu Biotech
- Beijing Taikesiman
- Foryou Medical
- Saikesaisi Holdings Group
- Biotemed
What is the 10-year outlook for the global Hemostatic Powder market?
What factors are driving Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic Powder market opportunities vary by end market size?
How does Hemostatic Powder break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Powder Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hemostatic Powder by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hemostatic Powder by Country/Region, 2018, 2022 & 2029
2.2 Hemostatic Powder Segment by Type
2.2.1 Absorbable Hemostatic Agent
2.2.2 Not Absorbable Hemostatic Agent
2.3 Hemostatic Powder Sales by Type
2.3.1 Global Hemostatic Powder Sales Market Share by Type (2018-2023)
2.3.2 Global Hemostatic Powder Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hemostatic Powder Sale Price by Type (2018-2023)
2.4 Hemostatic Powder Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Hemostatic Powder Sales by Application
2.5.1 Global Hemostatic Powder Sale Market Share by Application (2018-2023)
2.5.2 Global Hemostatic Powder Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hemostatic Powder Sale Price by Application (2018-2023)
3 GLOBAL HEMOSTATIC POWDER BY COMPANY
3.1 Global Hemostatic Powder Breakdown Data by Company
3.1.1 Global Hemostatic Powder Annual Sales by Company (2018-2023)
3.1.2 Global Hemostatic Powder Sales Market Share by Company (2018-2023)
3.2 Global Hemostatic Powder Annual Revenue by Company (2018-2023)
3.2.1 Global Hemostatic Powder Revenue by Company (2018-2023)
3.2.2 Global Hemostatic Powder Revenue Market Share by Company (2018-2023)
3.3 Global Hemostatic Powder Sale Price by Company
3.4 Key Manufacturers Hemostatic Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostatic Powder Product Location Distribution
3.4.2 Players Hemostatic Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEMOSTATIC POWDER BY GEOGRAPHIC REGION
4.1 World Historic Hemostatic Powder Market Size by Geographic Region (2018-2023)
4.1.1 Global Hemostatic Powder Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hemostatic Powder Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hemostatic Powder Market Size by Country/Region (2018-2023)
4.2.1 Global Hemostatic Powder Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hemostatic Powder Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hemostatic Powder Sales Growth
4.4 APAC Hemostatic Powder Sales Growth
4.5 Europe Hemostatic Powder Sales Growth
4.6 Middle East & Africa Hemostatic Powder Sales Growth
5 AMERICAS
5.1 Americas Hemostatic Powder Sales by Country
5.1.1 Americas Hemostatic Powder Sales by Country (2018-2023)
5.1.2 Americas Hemostatic Powder Revenue by Country (2018-2023)
5.2 Americas Hemostatic Powder Sales by Type
5.3 Americas Hemostatic Powder Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Powder Sales by Region
6.1.1 APAC Hemostatic Powder Sales by Region (2018-2023)
6.1.2 APAC Hemostatic Powder Revenue by Region (2018-2023)
6.2 APAC Hemostatic Powder Sales by Type
6.3 APAC Hemostatic Powder Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostatic Powder by Country
7.1.1 Europe Hemostatic Powder Sales by Country (2018-2023)
7.1.2 Europe Hemostatic Powder Revenue by Country (2018-2023)
7.2 Europe Hemostatic Powder Sales by Type
7.3 Europe Hemostatic Powder Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Powder by Country
8.1.1 Middle East & Africa Hemostatic Powder Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hemostatic Powder Revenue by Country (2018-2023)
8.2 Middle East & Africa Hemostatic Powder Sales by Type
8.3 Middle East & Africa Hemostatic Powder Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostatic Powder
10.3 Manufacturing Process Analysis of Hemostatic Powder
10.4 Industry Chain Structure of Hemostatic Powder
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostatic Powder Distributors
11.3 Hemostatic Powder Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATIC POWDER BY GEOGRAPHIC REGION
12.1 Global Hemostatic Powder Market Size Forecast by Region
12.1.1 Global Hemostatic Powder Forecast by Region (2024-2029)
12.1.2 Global Hemostatic Powder Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hemostatic Powder Forecast by Type
12.7 Global Hemostatic Powder Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Hemostatic Powder Product Portfolios and Specifications
13.1.3 Johnson & Johnson Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Hemostatic Powder Product Portfolios and Specifications
13.2.3 BD Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Baxter
13.3.1 Baxter Company Information
13.3.2 Baxter Hemostatic Powder Product Portfolios and Specifications
13.3.3 Baxter Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Baxter Main Business Overview
13.3.5 Baxter Latest Developments
13.4 B.Braun
13.4.1 B.Braun Company Information
13.4.2 B.Braun Hemostatic Powder Product Portfolios and Specifications
13.4.3 B.Braun Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B.Braun Main Business Overview
13.4.5 B.Braun Latest Developments
13.5 Cura Medical
13.5.1 Cura Medical Company Information
13.5.2 Cura Medical Hemostatic Powder Product Portfolios and Specifications
13.5.3 Cura Medical Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cura Medical Main Business Overview
13.5.5 Cura Medical Latest Developments
13.6 GELITA MEDICAL
13.6.1 GELITA MEDICAL Company Information
13.6.2 GELITA MEDICAL Hemostatic Powder Product Portfolios and Specifications
13.6.3 GELITA MEDICAL Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GELITA MEDICAL Main Business Overview
13.6.5 GELITA MEDICAL Latest Developments
13.7 Curasan AG
13.7.1 Curasan AG Company Information
13.7.2 Curasan AG Hemostatic Powder Product Portfolios and Specifications
13.7.3 Curasan AG Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Curasan AG Main Business Overview
13.7.5 Curasan AG Latest Developments
13.8 Meril Life Sciences
13.8.1 Meril Life Sciences Company Information
13.8.2 Meril Life Sciences Hemostatic Powder Product Portfolios and Specifications
13.8.3 Meril Life Sciences Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Meril Life Sciences Main Business Overview
13.8.5 Meril Life Sciences Latest Developments
13.9 Zhonghui Shengxi
13.9.1 Zhonghui Shengxi Company Information
13.9.2 Zhonghui Shengxi Hemostatic Powder Product Portfolios and Specifications
13.9.3 Zhonghui Shengxi Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zhonghui Shengxi Main Business Overview
13.9.5 Zhonghui Shengxi Latest Developments
13.10 Beijing Datsing Bio-tech
13.10.1 Beijing Datsing Bio-tech Company Information
13.10.2 Beijing Datsing Bio-tech Hemostatic Powder Product Portfolios and Specifications
13.10.3 Beijing Datsing Bio-tech Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Beijing Datsing Bio-tech Main Business Overview
13.10.5 Beijing Datsing Bio-tech Latest Developments
13.11 Guizhou Jin Jiu Biotech
13.11.1 Guizhou Jin Jiu Biotech Company Information
13.11.2 Guizhou Jin Jiu Biotech Hemostatic Powder Product Portfolios and Specifications
13.11.3 Guizhou Jin Jiu Biotech Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Guizhou Jin Jiu Biotech Main Business Overview
13.11.5 Guizhou Jin Jiu Biotech Latest Developments
13.12 Beijing Taikesiman
13.12.1 Beijing Taikesiman Company Information
13.12.2 Beijing Taikesiman Hemostatic Powder Product Portfolios and Specifications
13.12.3 Beijing Taikesiman Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Taikesiman Main Business Overview
13.12.5 Beijing Taikesiman Latest Developments
13.13 Foryou Medical
13.13.1 Foryou Medical Company Information
13.13.2 Foryou Medical Hemostatic Powder Product Portfolios and Specifications
13.13.3 Foryou Medical Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Foryou Medical Main Business Overview
13.13.5 Foryou Medical Latest Developments
13.14 Saikesaisi Holdings Group
13.14.1 Saikesaisi Holdings Group Company Information
13.14.2 Saikesaisi Holdings Group Hemostatic Powder Product Portfolios and Specifications
13.14.3 Saikesaisi Holdings Group Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Saikesaisi Holdings Group Main Business Overview
13.14.5 Saikesaisi Holdings Group Latest Developments
13.15 Biotemed
13.15.1 Biotemed Company Information
13.15.2 Biotemed Hemostatic Powder Product Portfolios and Specifications
13.15.3 Biotemed Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Biotemed Main Business Overview
13.15.5 Biotemed Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Powder Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hemostatic Powder by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hemostatic Powder by Country/Region, 2018, 2022 & 2029
2.2 Hemostatic Powder Segment by Type
2.2.1 Absorbable Hemostatic Agent
2.2.2 Not Absorbable Hemostatic Agent
2.3 Hemostatic Powder Sales by Type
2.3.1 Global Hemostatic Powder Sales Market Share by Type (2018-2023)
2.3.2 Global Hemostatic Powder Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hemostatic Powder Sale Price by Type (2018-2023)
2.4 Hemostatic Powder Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Hemostatic Powder Sales by Application
2.5.1 Global Hemostatic Powder Sale Market Share by Application (2018-2023)
2.5.2 Global Hemostatic Powder Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hemostatic Powder Sale Price by Application (2018-2023)
3 GLOBAL HEMOSTATIC POWDER BY COMPANY
3.1 Global Hemostatic Powder Breakdown Data by Company
3.1.1 Global Hemostatic Powder Annual Sales by Company (2018-2023)
3.1.2 Global Hemostatic Powder Sales Market Share by Company (2018-2023)
3.2 Global Hemostatic Powder Annual Revenue by Company (2018-2023)
3.2.1 Global Hemostatic Powder Revenue by Company (2018-2023)
3.2.2 Global Hemostatic Powder Revenue Market Share by Company (2018-2023)
3.3 Global Hemostatic Powder Sale Price by Company
3.4 Key Manufacturers Hemostatic Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostatic Powder Product Location Distribution
3.4.2 Players Hemostatic Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEMOSTATIC POWDER BY GEOGRAPHIC REGION
4.1 World Historic Hemostatic Powder Market Size by Geographic Region (2018-2023)
4.1.1 Global Hemostatic Powder Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hemostatic Powder Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hemostatic Powder Market Size by Country/Region (2018-2023)
4.2.1 Global Hemostatic Powder Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hemostatic Powder Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hemostatic Powder Sales Growth
4.4 APAC Hemostatic Powder Sales Growth
4.5 Europe Hemostatic Powder Sales Growth
4.6 Middle East & Africa Hemostatic Powder Sales Growth
5 AMERICAS
5.1 Americas Hemostatic Powder Sales by Country
5.1.1 Americas Hemostatic Powder Sales by Country (2018-2023)
5.1.2 Americas Hemostatic Powder Revenue by Country (2018-2023)
5.2 Americas Hemostatic Powder Sales by Type
5.3 Americas Hemostatic Powder Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Powder Sales by Region
6.1.1 APAC Hemostatic Powder Sales by Region (2018-2023)
6.1.2 APAC Hemostatic Powder Revenue by Region (2018-2023)
6.2 APAC Hemostatic Powder Sales by Type
6.3 APAC Hemostatic Powder Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostatic Powder by Country
7.1.1 Europe Hemostatic Powder Sales by Country (2018-2023)
7.1.2 Europe Hemostatic Powder Revenue by Country (2018-2023)
7.2 Europe Hemostatic Powder Sales by Type
7.3 Europe Hemostatic Powder Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Powder by Country
8.1.1 Middle East & Africa Hemostatic Powder Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hemostatic Powder Revenue by Country (2018-2023)
8.2 Middle East & Africa Hemostatic Powder Sales by Type
8.3 Middle East & Africa Hemostatic Powder Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostatic Powder
10.3 Manufacturing Process Analysis of Hemostatic Powder
10.4 Industry Chain Structure of Hemostatic Powder
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostatic Powder Distributors
11.3 Hemostatic Powder Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATIC POWDER BY GEOGRAPHIC REGION
12.1 Global Hemostatic Powder Market Size Forecast by Region
12.1.1 Global Hemostatic Powder Forecast by Region (2024-2029)
12.1.2 Global Hemostatic Powder Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hemostatic Powder Forecast by Type
12.7 Global Hemostatic Powder Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Hemostatic Powder Product Portfolios and Specifications
13.1.3 Johnson & Johnson Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Hemostatic Powder Product Portfolios and Specifications
13.2.3 BD Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Baxter
13.3.1 Baxter Company Information
13.3.2 Baxter Hemostatic Powder Product Portfolios and Specifications
13.3.3 Baxter Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Baxter Main Business Overview
13.3.5 Baxter Latest Developments
13.4 B.Braun
13.4.1 B.Braun Company Information
13.4.2 B.Braun Hemostatic Powder Product Portfolios and Specifications
13.4.3 B.Braun Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B.Braun Main Business Overview
13.4.5 B.Braun Latest Developments
13.5 Cura Medical
13.5.1 Cura Medical Company Information
13.5.2 Cura Medical Hemostatic Powder Product Portfolios and Specifications
13.5.3 Cura Medical Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cura Medical Main Business Overview
13.5.5 Cura Medical Latest Developments
13.6 GELITA MEDICAL
13.6.1 GELITA MEDICAL Company Information
13.6.2 GELITA MEDICAL Hemostatic Powder Product Portfolios and Specifications
13.6.3 GELITA MEDICAL Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GELITA MEDICAL Main Business Overview
13.6.5 GELITA MEDICAL Latest Developments
13.7 Curasan AG
13.7.1 Curasan AG Company Information
13.7.2 Curasan AG Hemostatic Powder Product Portfolios and Specifications
13.7.3 Curasan AG Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Curasan AG Main Business Overview
13.7.5 Curasan AG Latest Developments
13.8 Meril Life Sciences
13.8.1 Meril Life Sciences Company Information
13.8.2 Meril Life Sciences Hemostatic Powder Product Portfolios and Specifications
13.8.3 Meril Life Sciences Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Meril Life Sciences Main Business Overview
13.8.5 Meril Life Sciences Latest Developments
13.9 Zhonghui Shengxi
13.9.1 Zhonghui Shengxi Company Information
13.9.2 Zhonghui Shengxi Hemostatic Powder Product Portfolios and Specifications
13.9.3 Zhonghui Shengxi Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zhonghui Shengxi Main Business Overview
13.9.5 Zhonghui Shengxi Latest Developments
13.10 Beijing Datsing Bio-tech
13.10.1 Beijing Datsing Bio-tech Company Information
13.10.2 Beijing Datsing Bio-tech Hemostatic Powder Product Portfolios and Specifications
13.10.3 Beijing Datsing Bio-tech Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Beijing Datsing Bio-tech Main Business Overview
13.10.5 Beijing Datsing Bio-tech Latest Developments
13.11 Guizhou Jin Jiu Biotech
13.11.1 Guizhou Jin Jiu Biotech Company Information
13.11.2 Guizhou Jin Jiu Biotech Hemostatic Powder Product Portfolios and Specifications
13.11.3 Guizhou Jin Jiu Biotech Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Guizhou Jin Jiu Biotech Main Business Overview
13.11.5 Guizhou Jin Jiu Biotech Latest Developments
13.12 Beijing Taikesiman
13.12.1 Beijing Taikesiman Company Information
13.12.2 Beijing Taikesiman Hemostatic Powder Product Portfolios and Specifications
13.12.3 Beijing Taikesiman Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Taikesiman Main Business Overview
13.12.5 Beijing Taikesiman Latest Developments
13.13 Foryou Medical
13.13.1 Foryou Medical Company Information
13.13.2 Foryou Medical Hemostatic Powder Product Portfolios and Specifications
13.13.3 Foryou Medical Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Foryou Medical Main Business Overview
13.13.5 Foryou Medical Latest Developments
13.14 Saikesaisi Holdings Group
13.14.1 Saikesaisi Holdings Group Company Information
13.14.2 Saikesaisi Holdings Group Hemostatic Powder Product Portfolios and Specifications
13.14.3 Saikesaisi Holdings Group Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Saikesaisi Holdings Group Main Business Overview
13.14.5 Saikesaisi Holdings Group Latest Developments
13.15 Biotemed
13.15.1 Biotemed Company Information
13.15.2 Biotemed Hemostatic Powder Product Portfolios and Specifications
13.15.3 Biotemed Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Biotemed Main Business Overview
13.15.5 Biotemed Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemostatic Powder Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hemostatic Powder Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Absorbable Hemostatic Agent
Table 4. Major Players of Not Absorbable Hemostatic Agent
Table 5. Global Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 6. Global Hemostatic Powder Sales Market Share by Type (2018-2023)
Table 7. Global Hemostatic Powder Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hemostatic Powder Revenue Market Share by Type (2018-2023)
Table 9. Global Hemostatic Powder Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 11. Global Hemostatic Powder Sales Market Share by Application (2018-2023)
Table 12. Global Hemostatic Powder Revenue by Application (2018-2023)
Table 13. Global Hemostatic Powder Revenue Market Share by Application (2018-2023)
Table 14. Global Hemostatic Powder Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hemostatic Powder Sales by Company (2018-2023) & (K Units)
Table 16. Global Hemostatic Powder Sales Market Share by Company (2018-2023)
Table 17. Global Hemostatic Powder Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hemostatic Powder Revenue Market Share by Company (2018-2023)
Table 19. Global Hemostatic Powder Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hemostatic Powder Producing Area Distribution and Sales Area
Table 21. Players Hemostatic Powder Products Offered
Table 22. Hemostatic Powder Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hemostatic Powder Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hemostatic Powder Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hemostatic Powder Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hemostatic Powder Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hemostatic Powder Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hemostatic Powder Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hemostatic Powder Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hemostatic Powder Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 35. Americas Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 37. Americas Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hemostatic Powder Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hemostatic Powder Sales Market Share by Region (2018-2023)
Table 41. APAC Hemostatic Powder Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hemostatic Powder Revenue Market Share by Region (2018-2023)
Table 43. APAC Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 47. Europe Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 49. Europe Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hemostatic Powder
Table 58. Key Market Challenges & Risks of Hemostatic Powder
Table 59. Key Industry Trends of Hemostatic Powder
Table 60. Hemostatic Powder Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hemostatic Powder Distributors List
Table 63. Hemostatic Powder Customer List
Table 64. Global Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hemostatic Powder Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hemostatic Powder Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hemostatic Powder Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hemostatic Powder Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson & Johnson Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Hemostatic Powder Product Portfolios and Specifications
Table 80. Johnson & Johnson Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. BD Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 84. BD Hemostatic Powder Product Portfolios and Specifications
Table 85. BD Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BD Main Business
Table 87. BD Latest Developments
Table 88. Baxter Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 89. Baxter Hemostatic Powder Product Portfolios and Specifications
Table 90. Baxter Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Baxter Main Business
Table 92. Baxter Latest Developments
Table 93. B.Braun Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 94. B.Braun Hemostatic Powder Product Portfolios and Specifications
Table 95. B.Braun Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. B.Braun Main Business
Table 97. B.Braun Latest Developments
Table 98. Cura Medical Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 99. Cura Medical Hemostatic Powder Product Portfolios and Specifications
Table 100. Cura Medical Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cura Medical Main Business
Table 102. Cura Medical Latest Developments
Table 103. GELITA MEDICAL Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 104. GELITA MEDICAL Hemostatic Powder Product Portfolios and Specifications
Table 105. GELITA MEDICAL Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GELITA MEDICAL Main Business
Table 107. GELITA MEDICAL Latest Developments
Table 108. Curasan AG Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 109. Curasan AG Hemostatic Powder Product Portfolios and Specifications
Table 110. Curasan AG Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Curasan AG Main Business
Table 112. Curasan AG Latest Developments
Table 113. Meril Life Sciences Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 114. Meril Life Sciences Hemostatic Powder Product Portfolios and Specifications
Table 115. Meril Life Sciences Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Meril Life Sciences Main Business
Table 117. Meril Life Sciences Latest Developments
Table 118. Zhonghui Shengxi Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhonghui Shengxi Hemostatic Powder Product Portfolios and Specifications
Table 120. Zhonghui Shengxi Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Zhonghui Shengxi Main Business
Table 122. Zhonghui Shengxi Latest Developments
Table 123. Beijing Datsing Bio-tech Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 124. Beijing Datsing Bio-tech Hemostatic Powder Product Portfolios and Specifications
Table 125. Beijing Datsing Bio-tech Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Beijing Datsing Bio-tech Main Business
Table 127. Beijing Datsing Bio-tech Latest Developments
Table 128. Guizhou Jin Jiu Biotech Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 129. Guizhou Jin Jiu Biotech Hemostatic Powder Product Portfolios and Specifications
Table 130. Guizhou Jin Jiu Biotech Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Guizhou Jin Jiu Biotech Main Business
Table 132. Guizhou Jin Jiu Biotech Latest Developments
Table 133. Beijing Taikesiman Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Taikesiman Hemostatic Powder Product Portfolios and Specifications
Table 135. Beijing Taikesiman Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Beijing Taikesiman Main Business
Table 137. Beijing Taikesiman Latest Developments
Table 138. Foryou Medical Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 139. Foryou Medical Hemostatic Powder Product Portfolios and Specifications
Table 140. Foryou Medical Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Foryou Medical Main Business
Table 142. Foryou Medical Latest Developments
Table 143. Saikesaisi Holdings Group Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 144. Saikesaisi Holdings Group Hemostatic Powder Product Portfolios and Specifications
Table 145. Saikesaisi Holdings Group Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Saikesaisi Holdings Group Main Business
Table 147. Saikesaisi Holdings Group Latest Developments
Table 148. Biotemed Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 149. Biotemed Hemostatic Powder Product Portfolios and Specifications
Table 150. Biotemed Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Biotemed Main Business
Table 152. Biotemed Latest Developments
Table 1. Hemostatic Powder Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hemostatic Powder Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Absorbable Hemostatic Agent
Table 4. Major Players of Not Absorbable Hemostatic Agent
Table 5. Global Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 6. Global Hemostatic Powder Sales Market Share by Type (2018-2023)
Table 7. Global Hemostatic Powder Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hemostatic Powder Revenue Market Share by Type (2018-2023)
Table 9. Global Hemostatic Powder Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 11. Global Hemostatic Powder Sales Market Share by Application (2018-2023)
Table 12. Global Hemostatic Powder Revenue by Application (2018-2023)
Table 13. Global Hemostatic Powder Revenue Market Share by Application (2018-2023)
Table 14. Global Hemostatic Powder Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hemostatic Powder Sales by Company (2018-2023) & (K Units)
Table 16. Global Hemostatic Powder Sales Market Share by Company (2018-2023)
Table 17. Global Hemostatic Powder Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hemostatic Powder Revenue Market Share by Company (2018-2023)
Table 19. Global Hemostatic Powder Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hemostatic Powder Producing Area Distribution and Sales Area
Table 21. Players Hemostatic Powder Products Offered
Table 22. Hemostatic Powder Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hemostatic Powder Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hemostatic Powder Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hemostatic Powder Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hemostatic Powder Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hemostatic Powder Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hemostatic Powder Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hemostatic Powder Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hemostatic Powder Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 35. Americas Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 37. Americas Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hemostatic Powder Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hemostatic Powder Sales Market Share by Region (2018-2023)
Table 41. APAC Hemostatic Powder Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hemostatic Powder Revenue Market Share by Region (2018-2023)
Table 43. APAC Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 47. Europe Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 49. Europe Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hemostatic Powder
Table 58. Key Market Challenges & Risks of Hemostatic Powder
Table 59. Key Industry Trends of Hemostatic Powder
Table 60. Hemostatic Powder Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hemostatic Powder Distributors List
Table 63. Hemostatic Powder Customer List
Table 64. Global Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hemostatic Powder Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hemostatic Powder Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hemostatic Powder Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hemostatic Powder Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson & Johnson Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Hemostatic Powder Product Portfolios and Specifications
Table 80. Johnson & Johnson Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. BD Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 84. BD Hemostatic Powder Product Portfolios and Specifications
Table 85. BD Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BD Main Business
Table 87. BD Latest Developments
Table 88. Baxter Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 89. Baxter Hemostatic Powder Product Portfolios and Specifications
Table 90. Baxter Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Baxter Main Business
Table 92. Baxter Latest Developments
Table 93. B.Braun Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 94. B.Braun Hemostatic Powder Product Portfolios and Specifications
Table 95. B.Braun Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. B.Braun Main Business
Table 97. B.Braun Latest Developments
Table 98. Cura Medical Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 99. Cura Medical Hemostatic Powder Product Portfolios and Specifications
Table 100. Cura Medical Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cura Medical Main Business
Table 102. Cura Medical Latest Developments
Table 103. GELITA MEDICAL Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 104. GELITA MEDICAL Hemostatic Powder Product Portfolios and Specifications
Table 105. GELITA MEDICAL Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GELITA MEDICAL Main Business
Table 107. GELITA MEDICAL Latest Developments
Table 108. Curasan AG Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 109. Curasan AG Hemostatic Powder Product Portfolios and Specifications
Table 110. Curasan AG Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Curasan AG Main Business
Table 112. Curasan AG Latest Developments
Table 113. Meril Life Sciences Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 114. Meril Life Sciences Hemostatic Powder Product Portfolios and Specifications
Table 115. Meril Life Sciences Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Meril Life Sciences Main Business
Table 117. Meril Life Sciences Latest Developments
Table 118. Zhonghui Shengxi Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhonghui Shengxi Hemostatic Powder Product Portfolios and Specifications
Table 120. Zhonghui Shengxi Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Zhonghui Shengxi Main Business
Table 122. Zhonghui Shengxi Latest Developments
Table 123. Beijing Datsing Bio-tech Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 124. Beijing Datsing Bio-tech Hemostatic Powder Product Portfolios and Specifications
Table 125. Beijing Datsing Bio-tech Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Beijing Datsing Bio-tech Main Business
Table 127. Beijing Datsing Bio-tech Latest Developments
Table 128. Guizhou Jin Jiu Biotech Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 129. Guizhou Jin Jiu Biotech Hemostatic Powder Product Portfolios and Specifications
Table 130. Guizhou Jin Jiu Biotech Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Guizhou Jin Jiu Biotech Main Business
Table 132. Guizhou Jin Jiu Biotech Latest Developments
Table 133. Beijing Taikesiman Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Taikesiman Hemostatic Powder Product Portfolios and Specifications
Table 135. Beijing Taikesiman Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Beijing Taikesiman Main Business
Table 137. Beijing Taikesiman Latest Developments
Table 138. Foryou Medical Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 139. Foryou Medical Hemostatic Powder Product Portfolios and Specifications
Table 140. Foryou Medical Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Foryou Medical Main Business
Table 142. Foryou Medical Latest Developments
Table 143. Saikesaisi Holdings Group Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 144. Saikesaisi Holdings Group Hemostatic Powder Product Portfolios and Specifications
Table 145. Saikesaisi Holdings Group Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Saikesaisi Holdings Group Main Business
Table 147. Saikesaisi Holdings Group Latest Developments
Table 148. Biotemed Basic Information, Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 149. Biotemed Hemostatic Powder Product Portfolios and Specifications
Table 150. Biotemed Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Biotemed Main Business
Table 152. Biotemed Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hemostatic Powder
Figure 2. Hemostatic Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostatic Powder Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hemostatic Powder Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hemostatic Powder Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Absorbable Hemostatic Agent
Figure 10. Product Picture of Not Absorbable Hemostatic Agent
Figure 11. Global Hemostatic Powder Sales Market Share by Type in 2022
Figure 12. Global Hemostatic Powder Revenue Market Share by Type (2018-2023)
Figure 13. Hemostatic Powder Consumed in Hospital
Figure 14. Global Hemostatic Powder Market: Hospital (2018-2023) & (K Units)
Figure 15. Hemostatic Powder Consumed in Clinics
Figure 16. Global Hemostatic Powder Market: Clinics (2018-2023) & (K Units)
Figure 17. Hemostatic Powder Consumed in Other
Figure 18. Global Hemostatic Powder Market: Other (2018-2023) & (K Units)
Figure 19. Global Hemostatic Powder Sales Market Share by Application (2022)
Figure 20. Global Hemostatic Powder Revenue Market Share by Application in 2022
Figure 21. Hemostatic Powder Sales Market by Company in 2022 (K Units)
Figure 22. Global Hemostatic Powder Sales Market Share by Company in 2022
Figure 23. Hemostatic Powder Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Hemostatic Powder Revenue Market Share by Company in 2022
Figure 25. Global Hemostatic Powder Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Hemostatic Powder Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Hemostatic Powder Sales 2018-2023 (K Units)
Figure 28. Americas Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 29. APAC Hemostatic Powder Sales 2018-2023 (K Units)
Figure 30. APAC Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 31. Europe Hemostatic Powder Sales 2018-2023 (K Units)
Figure 32. Europe Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Hemostatic Powder Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 35. Americas Hemostatic Powder Sales Market Share by Country in 2022
Figure 36. Americas Hemostatic Powder Revenue Market Share by Country in 2022
Figure 37. Americas Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 38. Americas Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 39. United States Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Hemostatic Powder Sales Market Share by Region in 2022
Figure 44. APAC Hemostatic Powder Revenue Market Share by Regions in 2022
Figure 45. APAC Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 46. APAC Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 47. China Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Hemostatic Powder Sales Market Share by Country in 2022
Figure 55. Europe Hemostatic Powder Revenue Market Share by Country in 2022
Figure 56. Europe Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 57. Europe Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 58. Germany Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Hemostatic Powder Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Hemostatic Powder Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 67. Egypt Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Hemostatic Powder in 2022
Figure 73. Manufacturing Process Analysis of Hemostatic Powder
Figure 74. Industry Chain Structure of Hemostatic Powder
Figure 75. Channels of Distribution
Figure 76. Global Hemostatic Powder Sales Market Forecast by Region (2024-2029)
Figure 77. Global Hemostatic Powder Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Hemostatic Powder Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Hemostatic Powder Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Hemostatic Powder Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Hemostatic Powder Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Hemostatic Powder
Figure 2. Hemostatic Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostatic Powder Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hemostatic Powder Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hemostatic Powder Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Absorbable Hemostatic Agent
Figure 10. Product Picture of Not Absorbable Hemostatic Agent
Figure 11. Global Hemostatic Powder Sales Market Share by Type in 2022
Figure 12. Global Hemostatic Powder Revenue Market Share by Type (2018-2023)
Figure 13. Hemostatic Powder Consumed in Hospital
Figure 14. Global Hemostatic Powder Market: Hospital (2018-2023) & (K Units)
Figure 15. Hemostatic Powder Consumed in Clinics
Figure 16. Global Hemostatic Powder Market: Clinics (2018-2023) & (K Units)
Figure 17. Hemostatic Powder Consumed in Other
Figure 18. Global Hemostatic Powder Market: Other (2018-2023) & (K Units)
Figure 19. Global Hemostatic Powder Sales Market Share by Application (2022)
Figure 20. Global Hemostatic Powder Revenue Market Share by Application in 2022
Figure 21. Hemostatic Powder Sales Market by Company in 2022 (K Units)
Figure 22. Global Hemostatic Powder Sales Market Share by Company in 2022
Figure 23. Hemostatic Powder Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Hemostatic Powder Revenue Market Share by Company in 2022
Figure 25. Global Hemostatic Powder Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Hemostatic Powder Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Hemostatic Powder Sales 2018-2023 (K Units)
Figure 28. Americas Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 29. APAC Hemostatic Powder Sales 2018-2023 (K Units)
Figure 30. APAC Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 31. Europe Hemostatic Powder Sales 2018-2023 (K Units)
Figure 32. Europe Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Hemostatic Powder Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 35. Americas Hemostatic Powder Sales Market Share by Country in 2022
Figure 36. Americas Hemostatic Powder Revenue Market Share by Country in 2022
Figure 37. Americas Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 38. Americas Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 39. United States Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Hemostatic Powder Sales Market Share by Region in 2022
Figure 44. APAC Hemostatic Powder Revenue Market Share by Regions in 2022
Figure 45. APAC Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 46. APAC Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 47. China Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Hemostatic Powder Sales Market Share by Country in 2022
Figure 55. Europe Hemostatic Powder Revenue Market Share by Country in 2022
Figure 56. Europe Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 57. Europe Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 58. Germany Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Hemostatic Powder Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Hemostatic Powder Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 67. Egypt Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Hemostatic Powder in 2022
Figure 73. Manufacturing Process Analysis of Hemostatic Powder
Figure 74. Industry Chain Structure of Hemostatic Powder
Figure 75. Channels of Distribution
Figure 76. Global Hemostatic Powder Sales Market Forecast by Region (2024-2029)
Figure 77. Global Hemostatic Powder Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Hemostatic Powder Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Hemostatic Powder Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Hemostatic Powder Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Hemostatic Powder Revenue Market Share Forecast by Application (2024-2029)
